AffRegInc.i
Curation
Accueil
Racine
Curation
Exploration
Accueil
Racine
Accueil
Racine

Serveur d'exploration Tocilizumab - Curation (Accueil)

Index « AffRegInc.i » - entrée « Miyazaki »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Miyagi Children's Hospital < Miyazaki < Mo i Rana  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000902 (2019) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Yasuyo Abe [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Kiyoshi Aoyagi [Japon] ; Yukitaka Ueki [Japon]Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study.
001864 (2017) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Toshihiko Hidaka [Japon] ; Fumikazu Sakai [Japon] ; Mizue Hasegawa ; Yayoi Hashiba [Japon] ; Eiichi Suematsu [Japon] ; Hiroshi Tatsukawa [Japon] ; Akinari Mizokami [Japon] ; Shigeru Yoshizawa [Japon] ; Naoyuki Hirakata [Japon] ; Yukitaka Ueki [Japon]Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.
002047 (2015) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Yukitaka Ueki [Japon]Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study).
002847 (2013) Shunsuke Mori [Japon] ; Yukitaka Ueki [Japon] ; Yukihiro Akeda [Japon] ; Naoyuki Hirakata [Japon] ; Motohiro Oribe [Japon] ; Yoshiki Shiohira [Japon] ; Toshihiko Hidaka [Japon] ; Kazunori Oishi [Japon]Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
002E47 (2013) S. Miyauchi ; K. Umekita ; T. Hidaka [Japon] ; Y. Hashiba [Japon] ; T. Kawaguchi ; M. Matsuda ; K. Kubo ; S. Ueno ; N. Kusumoto ; I. Takajo ; Y. Kai [Japon] ; Y. Nagatomo ; A. OkayamaFRI0194 Treatment with anti-tumor necrosis factor (TNF) biologics to human t-lymphotropic virus type 1 (HTLV-1) positive patients with rheumatoid arthritis (RA): a case-control study
002F52 (2013) Takaaki Ogoshi [Japon] ; Takashi Kido [Japon] ; Kazuhiro Yatera [Japon] ; Keishi Oda [Japon] ; Toshinori Kawanami [Japon] ; Hiroshi Ishimoto [Japon] ; Noriho Sakamoto [Japon] ; Arisa Sano [Japon] ; Chiharu Yoshii [Japon] ; Shohei Shimajiri [Japon] ; Hiroshi Mukae [Japon]Assessment of Pathologically Diagnosed Patients with Castleman’s Disease associated with Diffuse Parenchymal Lung Involvement Using the Diagnostic Criteria for IgG4-Related Disease
003565 (2012) Shunsuke Mori [Japon] ; Yukitaka Ueki [Japon] ; Naoyuki Hirakata [Japon] ; Motohiro Oribe [Japon] ; Toshihiko Hidaka [Japon] ; Kazunori Oishi [Japon]Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i -k "Miyazaki" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i  \
                -Sk "Miyazaki" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Miyazaki
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021